Showing 1,221 - 1,240 results of 10,571 for search '(( significant decrease decrease ) OR ( significant effects decrease ))~', query time: 0.47s Refine Results
  1. 1221
  2. 1222
  3. 1223
  4. 1224
  5. 1225
  6. 1226
  7. 1227

    Supplementary file 1_Bupropion decreases plasma levels of asymmetric dimethylarginine and ameliorates renal injury by modulation of Ddah1, Oatp4c1, Oct2, and Mate1 in rats with ade... by Lulu Huang (469776)

    Published 2025
    “…In adenine-induced chronic renal injury rats, long-term administration of BUP significantly decreased the serum concentration of ADMA and creatinine by 12.78% and 38.85%, respectively, ameliorated interstitial lesions and fibrosis and upregulated Ddah1, Oatp4c1, Oct2, Mate1. …”
  8. 1228
  9. 1229
  10. 1230
  11. 1231
  12. 1232
  13. 1233
  14. 1234

    Risk of bias summary. by Duc Tran Quang (20564967)

    Published 2025
    “…The study encompassed 36 selected studies involving 44 effect sizes and 914 participants. The effectiveness of the TRE was found to vary across health conditions, with modest weight loss observed in healthy individuals (pooled effect size -1.04 Kg, 95% CI: -1.42 to -0.65) and more significant weight reduction seen in participants with chronic diseases (pooled effect size -3.33 Kg, 95% CI: -5.05 to -1.62) and overweight/obesity (pooled effect size -4.21 Kg, 95% CI: -5.23 to -3.10). …”
  15. 1235

    Criteria for study selection. by Duc Tran Quang (20564967)

    Published 2025
    “…The study encompassed 36 selected studies involving 44 effect sizes and 914 participants. The effectiveness of the TRE was found to vary across health conditions, with modest weight loss observed in healthy individuals (pooled effect size -1.04 Kg, 95% CI: -1.42 to -0.65) and more significant weight reduction seen in participants with chronic diseases (pooled effect size -3.33 Kg, 95% CI: -5.05 to -1.62) and overweight/obesity (pooled effect size -4.21 Kg, 95% CI: -5.23 to -3.10). …”
  16. 1236
  17. 1237
  18. 1238
  19. 1239
  20. 1240